Home / Healthcare/ New diabetic drug launched by Harcourts

New diabetic drug launched by Harcourts


Comments / {{hitsCtrl.values.hits}} Views / Wednesday, 28 February 2018 00:00


Harcourts recently launched a new diabetic drug Linagliptin (LINAPTIN) at Hotel Shangri-La Colombo. The symposium was provided over by well-known endocrinologists Professor Henry Rajarathnam, Dr. Prasad Katulanda and the speaker was Dr.Uditha Bulugahapitiya. 

The symposium was conducted by renowned Endocrinologists Dr.Henry Rajapaksa, Dr.Prasad Katulanda and the speaker Dr Uditha Bulugahapitiya on the use of Linaptin (Linagliptin ) the latest of the Gliptin. The drug is manufactured by one of the top Bangladeshi pharmaceutical companies - General Pharmaceuticals which is a WHO/GMP company. Speaking at the event the Managing Director Dr.Momanul Haq assured more new medicines and first time in Sri Lanka products. Dr. Ziad Rahmen Manager Global Marketing of General Pharma also made a presentation on the company of General Pharmaceuticals for the audience.

Harcourts Chairman Ahamed Rheyas confirmed that he would introduce many first time products in Sri Lanka in the near future. Over 100 top physicians and 15 Endocrinologists attended the event.  “Linaptin” is now available in Sri Lanka for an economical price for patients.

 


Share This Article


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Fruits, flowers and futile triumphalism at Galle Face?

Wednesday, 19 December 2018

Every morning, I play voyeur and watch that nice neighbourhood uncle pluck flowers to pooja-fy his guardian deities. He is quite religious about it. And industrious to boot. The problem, of course, is that he doesn’t restrict himself to his garden.


Will Kyaukpyu overtake Gwadar and Hambantota?

Wednesday, 19 December 2018

China last month signed a $1.3 billion contract for Myanmar’s Kyaukpyu port project. The figures doing rounds in media in the run up to this port deal were as high as $7.9 billion which had ignited enormous curiosities. The Chinese had been negoti


Things to do in a Democracy when you’re dead…

Tuesday, 18 December 2018

In yesterday’s column, I argued a case for not impeaching the chief executive of the coup that has left our country situation in ruins. At the end of a pitched battle between the forces of unconstitutional ambition on one hand and democratic resist


Tweaking the New Inland Revenue Act (Part II)

Tuesday, 18 December 2018

In the backdrop where the recent amendment to the country’s supreme law is called in question, it may be appropriate to recall that the passage of the new Inland Revenue (IR) Act through Parliament was far more controversial. Nevertheless, the new


Columnists More